Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOvoca Bio Regulatory News (OVB)

  • There is currently no data for OVB

Equity Fundraising

19 Nov 2007 07:02

Ovoca Gold PLC19 November 2007 Ovoca Gold PLC ("Ovoca" or the "Company") £4.5 million Placing Ovoca Gold Plc (AIM: OVG; IEX: OVX)("Ovoca" or the "Company") is pleased toannounce that it has agreed the terms of a conditional placing of 48,800,000 newordinary shares of €0.025 each ("Ordinary Share") with warrants at a price of9.25p (€0.14) per Ordinary Share (the 'Placing Shares'), raising gross proceedsof approximately £4.5 million ('the Placing'). The Placing price was at a 2.76%discount to the average mid closing market price on the AIM Market of the LondonStock Exchange of 9.51p per Ordinary share for the ten trading days prior to 16November 2007. The Company has issued to the subscribers of the Placing Shares(on the basis of 1 warrant for every 2 Ordinary Shares subscribed) an aggregateof 24,400,000 warrants to subscribe for new Ordinary Shares in the Company at anexercise price of 11p, exercisable at any time up to 15 November 2008. Thewarrants, which are transferable, will not be quoted on any market. The net proceeds of the Placing are to be used on the evaluation and developmentof the silver deposit Goltsovoye, located in the Magadan Oblast of north-eastRussia, in addition to advancing the Company's exploration projects in the KolaPeninsula, repaying all outstanding loans and for working capital purposes. A certain director of Ovoca will subscribe for the following Placing Shares: Placing Shares Resultant holding % of Enlarged subscribed for: of Ordinary Shares: Share Capital: Salyco Trading Company Ltd* 10,600,00 72,287,718 17.0997% Warrants received Resultant holding pursuant to the of Warrants: Placing: Salyco Trading Company Ltd* 5,300,000 11,386,957 *Salyco Trading Company is controlled by Mikhail Mogutov Application will be made to the Irish Stock Exchange and the London StockExchange for the placing shares to be admitted to trading on IEX and AIMrespectively Admission is expected to occur by 23 November 2007. Ovoca Resources Plc is an international exploration company with dual listing in London (OVG.L) and Ireland (OVX.IR), exploring for Precious and base metals in Russia. For further information please visit www.ovocagold.com or contact: Leonid Skoptsov - Ovoca Gold Plc Nick Bias / Alex Buck - Buck Bias (UK PR)Tel + 7 (0)495 648 2646 Tel: +44 (0)7887 920 530 / +44 (0)7932 740 452Email: leonid.skoptsov@ovocagold.com Email: nick@buckbias.com / alex@buckbias.com John Frain - Davy John O'Connor - Ovoca Gold PlcTel : +353 (0)1 679 6363 Tel: +353 (0)1 633 0523Email: john.frain@davy.ie Email: john.oconnor@ovocagold.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
29th Jul 20227:00 amRNSCompletion of Enrollment in Phase II Study
30th Jun 20227:00 amRNSAnnual Financial Report
7th Mar 20229:00 amRNSStatement re Russian Business Operations
23rd Feb 20224:41 pmRNSSecond Price Monitoring Extn
23rd Feb 20224:36 pmRNSPrice Monitoring Extension
22nd Feb 20223:30 pmRNSRussian Marketing Authorisation for Orenetide
31st Jan 20227:00 amRNSBoard Changes and Update
30th Dec 20217:00 amRNSDirectorate Change
4th Nov 20213:53 pmRNSHolding(s) in Company
4th Nov 20213:50 pmRNSDirector/PDMR Shareholding
4th Nov 20213:46 pmRNSBoard Change
14th Sep 20217:00 amRNSInterim Results
29th Jul 20215:00 pmRNSResult of AGM
24th Jun 20217:00 amRNSAnnual Report and Notice of AGM
10th Mar 20217:00 amRNSMigration of Participating Securities
16th Feb 20212:00 pmRNSResult of EGM
29th Jan 20217:00 amRNSFirst Patient Enrolled in Phase II Study - BP-101
25th Jan 20213:30 pmRNSNotice of EGM
5th Jan 20217:00 amRNSRe-Filing of Marketing Authorisation Application
17th Dec 20202:45 pmRNSResult of AGM
27th Nov 20203:08 pmRNSNotice of AGM
9th Oct 20207:00 amRNSAppointment of Chief Business Officer
2nd Oct 202011:06 amRNSSecond Price Monitoring Extn
2nd Oct 202011:00 amRNSPrice Monitoring Extension
2nd Oct 20209:05 amRNSSecond Price Monitoring Extn
2nd Oct 20209:00 amRNSPrice Monitoring Extension
2nd Oct 20207:00 amRNSUpdate re Russian Marketing Authorisation
28th Sep 20207:00 amRNSDeath of a Director
21st Sep 20207:00 amRNSInterim Results
14th Aug 202011:05 amRNSSecond Price Monitoring Extn
14th Aug 202011:00 amRNSPrice Monitoring Extension
26th Jun 20207:00 amRNSAnnual Report
14th Apr 20202:05 pmRNSSecond Price Monitoring Extn
14th Apr 20202:00 pmRNSPrice Monitoring Extension
24th Mar 20207:00 amRNSAcquisition of Remaining Minority Interest in IVIX
7th Nov 201912:45 pmRNSAttendance at Bio-Europe Conference
16th Sep 20197:00 amRNSInterim Results
12th Sep 20197:00 amRNSFiling of Marketing Authorisation Application
28th Aug 20197:00 amRNSDirectorate Change
8th Aug 20194:14 pmRNSResult of AGM
8th Aug 20199:05 amRNSSecond Price Monitoring Extn
8th Aug 20199:00 amRNSPrice Monitoring Extension
8th Aug 20197:00 amRNSAGM Statement
26th Jul 20197:00 amRNSDirectorate Change
25th Jul 20194:41 pmRNSSecond Price Monitoring Extn
25th Jul 20194:35 pmRNSPrice Monitoring Extension
28th Jun 20197:00 amRNSAnnual Report and Notice of AGM
23rd Apr 20197:00 amRNSUS and EU Clinical Development Plans
29th Mar 20197:00 amRNSDirector/PDMR Shareholding
27th Mar 20197:00 amRNSOperational Update & Additional Investment in IVIX

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.